5N. L. Harris,E. S. Jaffe,J. Diebold,G. Flandrin,H. K. Muller-Hermelink,J. Vardiman. Lymphoma classification – from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms[J] 2000,Annals of Oncology(1):3～10
6Jose Antonio Perdomo,Yoshio Naomoto,Minoru Haisa,Toshiyoshi Fujiwara,Madoka Hamada,Yasuo Yasuoka,Noriaki Tanaka. In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer[J] 1998,Journal of Cancer Research and Clinical Oncology(1):10～18
7Twentyman PR,Luscombe M. et al.A study of some variables in a tetrazolium dye(MTT)based assay for cell growth and chemoxensitivity[].British Journal of Cancer.1987
8Morimoto H,Yonehara S,Bonavida B.Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins[].Cancer Research.1993
9Safrit JT,Bonavida B.Senstivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: Correlation between down-regulation of tumor necrosis factor-messenger RNA inducation and overcoming resistance[].Cancer Research.1992
10Preisler HD,Raza A.Cell cycle studies in acute myelogenous leukemia[].Leukemia.1992
